ImmunoShield Therapeutics
May 06, 2024
Session
ImmunoShield Therapeutics seeks to enable the high-throughput biomanufacturing of hydrogel-based regenerative medicine products and the application of allogeneic cell products in the absence of chronic systemic immunosuppression, which will increase the safety of these products and broaden the eligible patient population.